GLP-1 receptor agonists work by stimulating GLP-1 receptors in the body, which leads to several beneficial effects: Increased insulin secretion: GLP-1 receptor agonists promote insulin release from the pancreas, helping to lower blood sugar levels Reduced glucagon secretion: These medications inhibit the release of glucagon, a hormone that increases blood sugar levels, thereby reducing glucose production Slowed gastric emptying: GLP-1 receptor agonists slow down the emptying of the stomach, leading to increased feelings of fullness and reduced appetite Additionally, tirzepatide, the active ingredient in Mounjaro works on GIP receptors
It is a primary reagent in studies investigating cellular pathways associated with collagen, fibroblast activity, and genomic expression within the extracellular matrix
and Chen, T
Others have step-therapy requirements
For best results, take the medication consistently
Chronic intermittent elemental diet improves growth failure in children with Crohn's disease